Compare Enveric Biosciences Inc (ENVB) vs Fiverr International Ltd (FVRR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Fiverr International Ltd — how do they compare? Enveric Biosciences Inc trades at $1.42 (market cap $5.32M), while Fiverr International Ltd trades at $11.82 (market cap $404.45M). The key difference: Fiverr International Ltd is far larger — about 76× Enveric Biosciences Inc's market cap, and Fiverr International Ltd is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | FVRR | |
|---|---|---|
Market Cap | $5.32M | $404.45M |
Sector | Health | Industrials |
52-Week High | $17.40 | $26.67 |
52-Week Low | $1.28 | $9.62 |
Enterprise Value | $408.82K | $135.05M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
Fiverr International (FVRR) trades at $11.82, up 6.78% in the last session, showing strong momentum despite recent volatility. The stock exhibits bullish technical signals with moving averages supporting upward movement. Fundamentally, revenue grew to $430.91M in 2025 with improving net margins, while valuation ratios like P/E of 14.61 and P/S of 0.97 suggest potential undervaluation. Recent news highlights Fiverr's upcoming Q2 2026 earnings report on July 29, 2026, amid mixed sentiment from financial media.
The outlook for FVRR hinges on execution of its strategic shift and Q2 earnings performance. Opportunities include attractive valuation multiples and operational cash flow growth, but risks involve declining active buyers and ongoing legal investigations. Analyst consensus leans neutral with 41% buy ratings, reflecting cautious optimism pending clearer business traction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →
